Careful quality control and a well-functioning QS system guarantee a consistently high product quality.

Aseptic Preparation
Microbial Safety

Inhibition of viability of microorganisms in [18F]-labelled radiopharmaceuticals

G. Jörg1,#, M. Fosselmann2, W. Leis2, F. Oberdorfer1, Ch. Fehsenfeld1

1 ZAG Zyklotron AG, Eggenstein-Leopoldshafen, Germany
2 BioChem GmbH, Karlsruhe, Germany
# Corresponding author


Introduction: Good Manufacturing Practice (GMP)-compliant production of radiopharmaceuticals for parenteral application requires great efforts in maintenance of clean room infrastructure and equipment in order to reliably guarantee the constant hygienic quality of the product (sterility). Terminal sterilisation of the product is not always possible due to short half-life or due to thermal instability of the compound. The typical method for sterilisation in these cases is sterile filtration prior to dispensing (distribution of product solution from bulk to patient vials). Therefore, aseptic processing techniques have to be in place in order to ensure sterility. Still, there remains some risk of microbial contamination of the product, and hence a risk for the patient to suffer from infection. Due to the short half-life of the labelling radionuclides, this aspect is aggravated by only retrospectively possible testing for sterility. This work investigated the potential of [18F]-radiation to intrinsically inactivate microorganisms (MO) that might have slipped through the aseptic process.
Methods: Defined numbers of viable cells of different bacterial strains and moulds were incubated with defined amounts of [18F]-activity. After decay of radiation the number of surviving viable cells was determined, D10-values were calculated and evaluated.
Results: The MOs tested exhibit a broad range of [18F]-radiation susceptibility, D10-values range from a sensitive 114 MBq/mL (46 Gy) to a durable 2,048 MBq/mL (790 Gy).
Conclusion: The intrinsic [18F]-radiation in radiopharmaceuticals is no safe measure to generally ensure sterility of the product solution in terms of "autosterilisation", because of dependence on various parameters.
Advances in Knowledge and Implications for Patient Care: This work presents for the first time experimental data on the influence of [18F]-radiation on MOs. The results suggest, that aseptic processing techniques are essential and that results of determination of sterility in radiopharmaceuticals should be considered with care (emphasis on importance of media fill campaigns).

® Published as: Jörg G., et al. Inhibition of viability of microorganisms in [18F]-labeled radiopharmaceuticals. Nucl Med Biol 44 (2016) 105-113, DOI:

® In cooperation with BioChem GmbH Karlsruhe:




Change of Ownership

Customer information on the change of ownership at ZAG Zyklotron AG: After many years of trusting cooperation, we...

>>>

[18]-FDG Drug Informations for Professionals as Update available

Updated 18FDG drug informations are available here for 

>>>

Tribology and Radionuclide Technique

Tribology and Radionuclid Technique ...

>>>

New Publication

The abstract of our new publication in "Applied Radiation and Isotopes" concerning the measurement of halfe lives of...

>>>

4 KIPROS 200 and 2 Concentration Units delivered

Four of our newly designed high-performance gastargets KIPROS 200 for the production of ultra pure Iodine 123 has...

>>>

News archive

Previous news >>> more